A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 29,777 shares of MRK stock, worth $2.96 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
29,777
Previous 29,387 1.33%
Holding current value
$2.96 Million
Previous $3.64 Million 7.06%
% of portfolio
0.18%
Previous 0.21%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $43,348 - $50,298
390 Added 1.33%
29,777 $3.38 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $172,948 - $185,745
1,397 Added 4.99%
29,387 $3.64 Million
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $3.17 Million - $3.69 Million
27,990 New
27,990 $3.69 Million
Q4 2023

Feb 07, 2024

SELL
$100.18 - $109.02 $57,002 - $62,032
-569 Reduced 1.29%
43,685 $4.76 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $56,725 - $62,995
-551 Reduced 1.23%
44,254 $4.56 Million
Q2 2023

Aug 09, 2023

BUY
$108.61 - $118.38 $327,133 - $356,560
3,012 Added 7.21%
44,805 $5.17 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $109,219 - $121,866
-1,061 Reduced 2.48%
41,793 $4.45 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $121,191 - $155,384
-1,386 Reduced 3.13%
42,854 $4.76 Million
Q3 2022

Nov 08, 2022

SELL
$84.53 - $94.96 $89,517 - $100,562
-1,059 Reduced 2.34%
44,240 $3.81 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $160,551 - $181,992
-1,923 Reduced 4.07%
45,299 $4.13 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $141,286 - $158,372
-1,922 Reduced 3.91%
47,222 $3.88 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $70,183 - $87,914
-971 Reduced 1.94%
49,144 $3.77 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $309,657 - $340,545
-4,320 Reduced 7.94%
50,115 $3.76 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $762,793 - $843,726
-10,849 Reduced 16.62%
54,435 $4.23 Million
Q1 2021

May 07, 2021

SELL
$68.86 - $81.11 $202,723 - $238,787
-2,944 Reduced 4.31%
65,284 $5.03 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $133,779 - $148,467
-1,864 Reduced 2.66%
68,228 $5.58 Million
Q3 2020

Oct 28, 2020

SELL
$73.18 - $82.95 $148,628 - $168,471
-2,031 Reduced 2.82%
70,092 $5.81 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $144,924 - $164,907
2,058 Added 2.94%
72,123 $5.58 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $37,065 - $51,374
585 Added 0.84%
70,065 $5.39 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $356,480 - $402,246
-4,595 Reduced 6.2%
69,480 $6.32 Million
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $760 - $829
-10 Reduced 0.01%
74,075 $6.24 Million
Q2 2019

Aug 06, 2019

SELL
$69.84 - $81.59 $117,401 - $137,152
-1,681 Reduced 2.22%
74,085 $6.21 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $768,511 - $876,531
11,045 Added 17.07%
75,766 $6.3 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $1.29 Million - $1.5 Million
19,819 Added 44.14%
64,721 $4.95 Million
Q3 2018

Nov 26, 2018

SELL
$57.69 - $67.84 $52,901 - $62,209
-917 Reduced 2.0%
44,902 $3.19 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $123,364 - $144,940
2,427 Added 5.59%
45,819 $2.78 Million
Q1 2018

Jul 26, 2018

BUY
$50.96 - $59.23 $2.09 Million - $2.43 Million
41,028 Added 1735.53%
43,392 $2.36 Million
Q1 2018

May 03, 2018

SELL
$50.96 - $59.23 $2.12 Million - $2.46 Million
-41,543 Reduced 94.62%
2,364 $43.4 Million
Q4 2017

Feb 06, 2018

SELL
$51.62 - $61.64 $56,782 - $67,804
-1,100 Reduced 2.44%
43,907 $0
Q3 2017

Nov 09, 2017

SELL
$58.67 - $63.13 $196,544 - $211,485
-3,350 Reduced 6.93%
45,007 $2.88 Million
Q2 2017

Aug 14, 2017

BUY
N/A
48,357
48,357 $3.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.